Blocker of integrin binding to its endothelial receptor (VCAM-1)

Novel inhibitor of Cdc42 that act by blocking nucleotide binding with no effect on RhoA or Rac

Novel lopinavir analogue against COVID-19, forming the most stable complex with the Mpro

Novel Inhibitor of the Major Facilitator Superfamily (MFS) of Efflux Pump Transporters.

Potent inhibitor of cancer cell growth with microtubule-binding activity

Potent inhibitor of ROCK2 enzymatic activity

Novel Stimulator of Hepatitis C Virus NS3 Helicase-Catalyzed ATP Hydrolysis

Potent inhibitor of HIV-1 nucleocapsid (NC)-DNA interaction; specifically bound NC with nanomolar affinity, and showed modest anti-HIV-1 activity in ex vivo cell assays

Potent inhibitor of cancer cell growth with microtubule-binding activity

Novel specific inhibitor of bacterial AddAB helicase-nuclease DNA repair enzyme

Inhibitor of PLAP and TNAP

Inhibitor of human tyrosyl-DNA phosphodiesterase 1 (TDP1); Delayed death inhibitor of the malarial parasite plastid; Inhibitor of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1); Inhibit

Platelet activation inhibitor

Novel 3C-like protease inhibitor of SARS-CoV-2

Altered peptide ligand containing a novel CD4 T-cell epitope of human heat shock protein 60 (83-109)

Cell permeable caged inositol triphosphate, promoting Ca2+-release from internal stores under UV photolysis

Noncompetitive inhibitor of Candida albicans growth and activity of (1-3)-beta-glucan synthase

ß-Adrenergic agonist

5-HT2 antagonist

Agonist of the 5-HT1 and 5-HT4 receptors and as an antagonist of the 5-HT2 receptors

Novel modulator of SLC6A19, robustly, selectively, and reproducibly inhibiting SLC6A19

Broad-spectrum antimicrobial carboxyfluoroquinoline, interfering with the bacterial DNA gyrase, inhibiting the DNA synthesis, and preventing bacterial cell growth